Board of Directors
Dr. Anand Tharmaratnam
Anand brings over 20 years of experience in global drug development and the CRO industry. He was previously the president of Asia Pacific at IQVIA. Anand is a medical doctor by training and graduated from the University College London, UK and trained in the anaesthesia.
Mr. Joel Thickins
Joel is a Partner at TPG Capital and leads the firm’s investment program in the ANZ region as Head of Australia and New Zealand. Joel has previously served on the board of Inghams Group Limited and Accolade Wines Holding Australia Pty Limited.
Before joining TPG, Joel was a director at CPE Capital (formerly known as CHAMP Private Equity) where he was responsible for the company’s activities in the industrial, agricultural services and consumer markets.
Dr. Fred Cohen
Fred Cohen은 TPG의 선임 고문이며 TPG Biotech 의 공동 창립자 겸 파트너였습니다. Fred는 Biocryst(BCRX) 및 CareDx(CDNA) 등 여러 생명공학 및 제약회사에서 이사직을 역임했으며 현재는 비영리 자폐증 지원 조직인 Sweetwater Spectrum의 공동 설립자입니다.
Mr. Vincent Wong
Vincent Wong is a Managing Director with TPG Capital and is based in Melbourne, where he works in TPG’s Australian team. Prior to joining TPG in 2011, Vincent served in the corporate advisory division at Goldman Sachs Australia. Vincent graduated from the University of Melbourne with BCommerce and BLaws (Honors).
Ms. Cai Li (蔡俐)
Lydia Cai is a Managing Director with TPG Capital based in Beijing and leads TPG’s healthcare investments in the Greater China area. Prior to joining TPG in 2011, Lydia was an investment associate at HAO Capital, a China-focused early stage private equity fund focusing on growth-stage healthcare investments.
Dr. John Moller
John은 2014년 1월 노보텍에 합류하여 노보텍의 아시아 운영 부문을 이끌고 있습니다. 노보텍에 입사하기 전 John은 IVF Australia 및 Queensland Fertility Group에서 상무이사직을 역임했으며 모회사인 Virtus Health의 이사였습니다. John은 의학박사입니다.
Ms. Elaine Cheung (張綺玲)
Ms. Cheung is responsible for providing independent advice to the Board. She chairs the Audit Committee. Ms. Cheung has more than 30 years of corporate experience in the Asia-Pacific region. In January 1990, Ms. Cheung graduated from San Francisco State University with a bachelor of science degree, majoring in business administration.
Senior Management
Dr. John Moller
John은 2014년 1월 노보텍에 합류하여 노보텍의 아시아 운영 부문을 이끌고 있습니다. 노보텍에 입사하기 전 John은 IVF Australia 및 Queensland Fertility Group에서 상무이사직을 역임했으며 모회사인 Virtus Health의 이사였습니다. John은 의학박사입니다.
Michael stibilj
Michael has 25 years of experience in the CRO Industry. Prior to joining Novotech in 2017, Michael spent 15 years building and leading operations across Asia for Quintiles/IQVIA, and was senior advisor for TPG Capital.
Dr. Judith Ng-Cashin
2023년 노보텍에 입사한 Judith는 20년 동안 글로벌 제약회사, 바이오텍 및 CRO에서 쌓은 경험을 바탕으로 최고 의료 책임자(CMO) 및 최고 전략 책임자(CSO)를 포함한 여러 고위 임원직을 역임하였습니다. 미국에서 근무하는 Judith는 노보텍의 글로벌 다국가 후기 임상시험 전략을 추진하는 동시에 고객들과 환자들에게 높은 수준의 의료 서비스를 제공할 수 있도록 앞장서고 있습니다.
Rob Speedie
Rob was most recently a Managing Director in the TPG Capital Operations Team and lead a number of Strategic Initiatives across TPG’s portfolio, including time as the CPOO at Greencross. Prior to TPG, Rob was a Partner at PwC where he spent a total of 19 years. His roles at PWC included 10 years as a Transaction Services professional and 10 years in audit services across Australia, Asia and US. He worked in a range of industries including the pharmaceutical sector. Rob acted as Investigating Accountant and Signing Partner on multiple IPOs on the ASX, was a member of PwCs technical accounting issues escalation committee and has significant experience in financial due diligence.
Barry Murphy
Barry는 2014년 7월 입사하여 노보텍의 비즈니스 개발 팀을 이끌고 있습니다. Barry는 Trinity College Dublin 졸업 후 약사로 시작했습니다. 그는 ICON에서 임상 연구 경력을 시작했으며 더블린과 시드니에서 근무하였습니다.
Andy Liu
Andy worked at Covance, Inc., a global CRO, for more than 10 years in a number of executive positions. Most recently, he was General Manager of Covance's Central Laboratory Service, Asia Pacific, where he led a large multi-functional team of across multiple sites in APAC. Andy holds an MBA from the University of Chicago, an MS in Electrical Engineering from the Rose-Hulman Institute of Technology, and a BS in Electrical Engineering from Tsinghua University.
Veronica Holloway
Veronica는 2014년 5월 노보텍에 입사하여 노보텍의 법률 부서를 구축했습니다. 노보텍에 합류하기 전, Veronica는 EY에서 선임 변호사, Clayton Utz에서 선임 사무 변호사 및 Novartis Pharmaceuticals Australia Pty Limited에서 법무 자문위원(파견직)으로 활동했습니다. Veronica는 BA/LLB/LLM을 취득했습니다.
Angela Edwardson
Angela는 2015년11월에 노보텍에 입사하여 현재는인사운영 전략, 조직 개발, 보수 & 보상 및 직장 건강 및 안전 등을 담당하고 있습니다. Angela는 아시아 태평양 지역에서 선도적인 CRO 달성이라는 노보텍의 비전을 열정적으로 추구하고 있습니다.